Considering the remainder factors, VIRMA transcript levels were reported to be significantly higher in hepatocellular carcinoma, [57], whereas in glioblastoma, ALKBH5 findings were in line with our observations in BlCa [43]. Here, VIRMA is linked to hepatocellular carcinoma.